Torren Management
ABBV icon

Torren Management’s AbbVie ABBV Stock Holding History

Torren Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.3K Buy
62
+17
+38% +$4.36K 0.01% 165
2026
Q2 		$11.3K Hold
45
– – 0.01% 199
2026
Q1 		$9.8K Sell
45
-1,257
-97% -$279K ﹤0.01% 202
2025
Q4 		$298K Buy
+1,302
New +$297K 0.15% 48

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Torren Management's ABBV Position: Q3 2026 in Review

Torren Management increased its AbbVie (ABBV) stake by 38% in Q3 2026, buying an estimated $4.36K and bringing the position to 62 shares worth $16.3K. The position accounts for 0.01% of the portfolio, ranked #165.

Torren Management first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $298K in Q4 2025. 2,685 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Torren Management held 62 shares of AbbVie worth $16.3K as of Q3 2026.
  • Torren Management bought 17 AbbVie shares in Q3 2026, an estimated $4.36K.
  • AbbVie made up 0.01% of Torren Management's portfolio in Q3 2026, its #165 holding.
  • Torren Management first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • Torren Management's AbbVie position peaked at $298K in Q4 2025.
  • 2,685 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Torren Management's 13F filing for Q3 2026, filed 29 Oct 2026.